NEK2 and familial pancreatic carcinoma: NEK2 interacts with and phosphorylates PD-L1 at the T194/T210 residues, maintaining its stability, and thus inhibition of NEK2 leads to expedited degradation of PD-L1, activating cytotoxic T cells to obliterate pancreatic cancer cells (Fig. 8).